Dermatology

The substantial data supporting platelet-rich plasma (PRP) therapy and exosomes for androgenic alopecia have yet to convince the FDA that they deserve regulatory approval.

The patient reports intermittent fever and hand pain as well as weakness, watery diarrhea, and weight loss.

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving patients uncertain about how they’ll be able to afford their medications.